Diagnos Inc.
ADK.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -21.50% | -21.11% | -21.38% | -23.18% | -17.82% |
| Total Depreciation and Amortization | 10.87% | 25.10% | 23.88% | 20.08% | 2.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.85% | 30.49% | 42.03% | 67.70% | 75.01% |
| Change in Net Operating Assets | -134.12% | -94.69% | -192.53% | 75.73% | 10,238.89% |
| Cash from Operations | -43.27% | -30.78% | -21.45% | -11.36% | 3.98% |
| Capital Expenditure | 52.24% | 60.10% | 60.99% | 55.25% | -91.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -945.55% | -459.11% | 34.52% | -100.97% | -47.68% |
| Cash from Investing | -1,035.78% | -416.69% | 36.56% | -103.18% | -51.27% |
| Total Debt Issued | -100.00% | -100.00% | -100.00% | -47.59% | -52.17% |
| Total Debt Repaid | 31.87% | 29.15% | 31.08% | 35.67% | -161.32% |
| Issuance of Common Stock | 444.14% | 1,017.59% | 941.95% | -- | 1,431.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.39% | -63.78% | -71.60% | -121.71% | -321.00% |
| Cash from Financing | 220.50% | 109.22% | -4.91% | 62.00% | -25.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 62.12% | 730.90% | -280.95% | 42.52% | -108.24% |
